After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

"This is a new chapter in the history of our company," Novavax CEO John Jacobs told Yahoo Finance in an interview Friday. Novavax struggled after its COVID-19 vaccine was delayed by manufacturing ...

"Today, we announce the beginning of an exciting new chapter for Novavax with the launch of a strategically important partnership with one of the world's leading vaccine companies," NVAX CEO John ...

including our shareholders," Novavax CEO John Jacobs told CNBC in an interview. Under the agreement, Sanofi will take a less ...

Novavax’s COVID-19 vaccine produced higher ... In this video from JPM 2025, pharmaphorum chats with SIFI CEO and Chairman Fabrizio Chines about a new treatment for acanthamoeba keratitis.

A clinical trial has found that Novavax’ COVID-19 vaccine is 86% protective against the UK variant of SARS-CoV-2, only slightly lower than the 96% efficacy seen with the original strain of the ...